Gugliucci Alejandro, Caccavello Russell, Kotani Kazuhiko, Kimura Satoshi
Redox Rep. 2014 Jul;19(4):154-60. doi: 10.1179/1351000214Y.0000000084. Epub 2014 Feb 14.
We have recently demonstrated the quick ex vivo transfer of paraoxonase 1 (PON1) activity from high-density lipoprotein (HDL) to small, dense low-density lipoprotein (sdLDL). We set out to assess whether sdLDL contains active PON1 in vivo.
We conducted a nested case-control, proof of principle study with the Japanese healthy subjects with normal lipids (n = 23) and age and gender-paired dyslipidemic subjects (n = 17). Lipid panels, lactonase and arylesterase assays, and PON1 zymogram in the LDL and HDL subclasses were assessed.
PON1 specific activity in the high-molecular weight lipoprotein fraction corresponding to LDL migration was found in 48% of normo and in 29% of dyslipidemic Japanese subjects. This band co-localizes with apoB100 and not Lp(a) and displays a lower molecular mass than the bulk of LDL.
We provide evidence, for the first time, that native sdLDL contains up to 4% of the total PON1 activity in the serum of up to 48% of the Japanese subjects. Could the PON1-containing sdLDL represent a set of particles with a defense mechanism from oxidation and therefore its levels actually prove to be atheroprotective? If further studies confirm this contention, a zymogram of PON1 in LDL subclasses could be a functional assay that complements the current methods that only inform on the size and lipid concentration of these particles.
我们最近证明了对氧磷酶1(PON1)活性可在体外从高密度脂蛋白(HDL)快速转移至小而密的低密度脂蛋白(sdLDL)。我们着手评估sdLDL在体内是否含有活性PON1。
我们对血脂正常的日本健康受试者(n = 23)以及年龄和性别匹配的血脂异常受试者(n = 17)进行了一项巢式病例对照的原理验证研究。评估了脂质谱、内酯酶和芳基酯酶测定以及LDL和HDL亚类中的PON1酶谱。
在48%的血脂正常和29%的血脂异常日本受试者中,在对应于LDL迁移的高分子量脂蛋白组分中发现了PON1比活性。该条带与载脂蛋白B100共定位,而非与脂蛋白(a)共定位,并且显示出比大部分LDL更低的分子量。
我们首次提供证据表明,在高达48%的日本受试者血清中,天然sdLDL含有高达血清总PON1活性的4%。含有PON1的sdLDL是否可能代表一组具有抗氧化防御机制的颗粒,因此其水平实际上被证明具有抗动脉粥样硬化作用?如果进一步的研究证实了这一论点,LDL亚类中的PON1酶谱可能是一种功能测定方法,可补充目前仅告知这些颗粒大小和脂质浓度的方法。